{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T13:08:37Z","timestamp":1778418517821,"version":"3.51.4"},"reference-count":33,"publisher":"Brieflands","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["brieflands.com"],"crossmark-restriction":false},"short-container-title":["Iran J Pharm Res"],"abstract":"<jats:p>Background: Mild traumatic brain injury (mTBI) may disrupt hepatic cytochrome P-450 enzyme activity, potentially altering drug pharmacokinetics. Objectives: This study investigated the impact of mTBI on CYP2D6 activity and the restorative effects of melatonin and vitamin C supplementation. Methods: Mild traumatic brain injury was induced in rats using a modified weight-drop model, which were then assigned to treatment or control groups. CYP2D6 activity was assessed at multiple time points post-injury using metabolic ratios of tramadol and mirtazapine through isolated liver perfusion. All experimental procedures were conducted with the investigator blinded to group assignments. Results: Mild traumatic brain injury significantly suppressed CYP2D6 activity on day 3, with partial recovery by day 7. While tramadol metabolism normalized by day 28, mirtazapine metabolism remained impaired in non-supplemented groups. Supplementation accelerated CYP2D6 recovery, showing statistically significant change by day 7. By day 28, supplemented groups exhibited metabolic ratios surpassing baseline levels. Conclusions: Mild traumatic brain injury induces transient suppression of CYP2D6 activity, which was attenuated in antioxidant-treated groups in this preclinical model. Further studies are needed to explore the clinical relevance of these findings.<\/jats:p>","DOI":"10.5812\/ijpr-164903","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T12:33:25Z","timestamp":1778416405000},"update-policy":"https:\/\/doi.org\/10.5812\/crossmark_update_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation"],"prefix":"10.5812","volume":"26","author":[{"given":"Kaveh","family":"Berenjian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziba","family":"Gholipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Khoshayand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Rouini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalda","family":"Hosseinzadeh Ardakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3819","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"key-A164903REF1-1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00309-X"},{"key":"key-A164903REF2-2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20160025"},{"key":"key-A164903REF3-3","doi-asserted-by":"publisher","DOI":"10.1177\/11772719221105145"},{"key":"key-A164903REF4-4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6609a1"},{"key":"key-A164903REF5-5","doi-asserted-by":"publisher","DOI":"10.3791\/51820"},{"key":"key-A164903REF6-6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020293"},{"key":"key-A164903REF7-7","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.061093"},{"key":"key-A164903REF8-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107627"},{"key":"key-A164903REF9-9","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-020-00350-z"},{"key":"key-A164903REF10-10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"key-A164903REF11-11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.733935"},{"key":"key-A164903REF12-12","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13071042"},{"key":"key-A164903REF13-13","doi-asserted-by":"publisher","DOI":"10.3791\/62606"},{"key":"key-A164903REF14-14","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2020.7443"},{"key":"key-A164903REF15-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2022.102143"},{"key":"key-A164903REF16-16","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322009001200012"},{"key":"key-A164903REF17-17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2005.10.039"},{"key":"key-A164903REF18-18","doi-asserted-by":"publisher","DOI":"10.1186\/s40199-017-0183-z"},{"key":"key-A164903REF19-19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.431916"},{"key":"key-A164903REF20-20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00990"},{"key":"key-A164903REF21-21","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2023.0419"},{"key":"key-A164903REF22-22","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-016-0351-6"},{"key":"key-A164903REF23-23","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2008.0542"},{"key":"key-A164903REF24-24","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000155989.54344.e0"},{"key":"key-A164903REF25-25","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9792-y"},{"key":"key-A164903REF26-26","doi-asserted-by":"publisher","DOI":"10.18502\/acta.v60i1.8323"},{"key":"key-A164903REF27-27","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746040-00004"},{"key":"key-A164903REF28-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2024.07.004"},{"issue":"2","key":"key-A164903REF29-29","first-page":"278","volume":"41","author":"Saidu\u00a0UF","year":"2024","journal-title":"J Exp Clin Med."},{"key":"key-A164903REF30-30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010025"},{"key":"key-A164903REF31-31","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070760"},{"key":"key-A164903REF32-32","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_932_2022"},{"key":"key-A164903REF33-33","doi-asserted-by":"publisher","DOI":"10.2174\/1381612819666131119102155"}],"container-title":["Iranian Journal of Pharmaceutical Research"],"original-title":[],"link":[{"URL":"https:\/\/brieflands.com\/journals\/ijpr\/articles\/164903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/brieflands.com\/journals\/ijpr\/articles\/164903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T12:33:26Z","timestamp":1778416406000},"score":1,"resource":{"primary":{"URL":"https:\/\/brieflands.com\/journals\/ijpr\/articles\/164903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,8]]}},"alternative-id":["c8682c352fb491dc5f42c1761f10144b8b9abeee"],"URL":"https:\/\/doi.org\/10.5812\/ijpr-164903","relation":{},"ISSN":["1726-6890"],"issn-type":[{"value":"1726-6890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]}}}